Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
Learn more
BIO Statement on Reintroduction of the PASTEUR Act
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Elects Dr. Ted W. Love as New Board Chair
June 5, 2023
2023-2024 BIO Executive Committee is Accomplished, Energetic and Diverse Boston, Mass. (June 5, 2023) – Biotechnology Innovation Organization (BIO) is proud to announce its newly elected Executive Committee Directors following Board elections that…
BIO Applauds USTR for Taking Next Step to Return Mexico to Science-Based Policy
June 2, 2023
The following statement may be attributed to Nancy Travis, vice president for international affairs, BIO. “The Biotechnology Innovation Organization supports the decision, announced today, by the Office of the U.S. Trade Representative to request…
BIO Statement on PIPs Rule: EPA Misses Opportunity to Advance Food, Ag Innovation
May 25, 2023
The following statement concerning the Environmental Protection Agency’s final rule on regulation of Plant Incorporated Protectants (PIPs) under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) may be attributed to John Murphy, chief…
FDA Commissioner Dr. Robert Califf to Address Medical Misinformation During Keynote Address at BIO International Convention
May 25, 2023
BIO CEO Rachel King and Califf will discuss issues impacting FDA and the biotech communityWASHINGTON - (May 25, 2023) – Robert Califf, commissioner of the Food and Drug Administration, will be the keynote speaker on day three of the 2023 BIO…
Katie Couric, Award-Winning Journalist and Health Advocate to Headline BIO International Convention
May 16, 2023
BIO CEO Rachel King and Couric to Discuss How Standing Up for Science and Patients Are at the Heart of BiotechWASHINGTON - (May 16, 2023) – Katie Couric, award-winning journalist, New York Times best-selling author, and longtime cancer advocate…
Nominate Biotech Heroes for BIO's Impact Awards
May 8, 2023
Nominations are now open for two prestigious awards to honor today’s biotech heroes—innovators who are driving discoveries to strengthen agricultural, environmental and economic resiliency. Collectively known as the Biotechnology Innovation…
Organizations Focused on Fight Against Superbugs Celebrate Reintroduction of the PASTEUR Act
April 27, 2023
Groups urging need for revitalizing antimicrobial development call for passage of the bill this year  Today, five prominent national organizations — the Biotechnology Innovation Organization, the Cystic Fibrosis Foundation, the Infectious…
Call for Sessions for BIO's Impact Ag & Environment Conference
April 27, 2023
BIO’s Impact Ag & Environment Conference, Sept. 19-20, 2023, in Raleigh, N.C., is an opportunity for companies and non-governmental organizations working across agriculture, bioprocessing, and climate adaptation/mitigation to connect and…
BIO to redouble efforts to ensure regulatory decision-making is "grounded in scientific and medical expertise"
April 21, 2023
The Supreme Court ruled today that mifepristone will remain accessible during the appeals process of the April 7 Texas ruling that would have declared the Food and Drug Administration (FDA) approval of the drug invalid.  BIO interim…
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS
April 11, 2023
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS “We will continue to organize and mobilize America’s scientific community to challenge this unprecedented effort to undermine…